RYTMNasdaq United States
Market cap
$7.961 B
$115.63 +3.15%
Close of 7 Aug 2026
Revenue
$189.8M
#2311 by revenue
Earnings
-$196.5K
Loss-making
Shares outstanding
68,852,082
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Rhythm Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.